Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The study suggests that hypothyroidism may cause alopecia areata.

The document explains various skin conditions and their treatments.

New psoriasis treatments are effective but come with side effects and risks.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Hair follicles prevent NK cell attacks to avoid hair loss.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.